Home > Articles

  • Print
  • + Share This
This chapter is from the book

Ethnicity, religion, and the gene-hunting companies

As Nancy Wexler's Venezuelan pedigree for Huntington's chorea shows, certain populations are particularly suitable candidates in the search for disease genes. For example, Mormons are a favorable population for the discovery of new disease genes. Mark Skolnick, a University of Utah scientist, realized this many years ago when he became interested in the genetics of breast cancer. In 1991, he was one of the founders of Myriad Genetics of Salt Lake City, Utah, and is currently the chief scientific officer of the company.17

Utah's Mormon population was established in the 1840s. Its founders were often polygamous, had large families, and seldom moved. Mormons also marry young so the time span between generations is relatively short. Furthermore, they keep meticulous genealogical records and Myriad Genetics has the rights to these records. As a result, the company has been involved in the identification of the two genes involved in 80% of hereditary breast cancer cases (BRCA1, BRCA2) as well as genes important in prostate cancer, colon cancer, melanoma, and also genes disposing individuals to risks other than cancer. The company has developed predictive tests for these genes. Their gene-searching technology is especially useful for such cancer genes because, in addition to having available a computerized genealogy of Mormon pioneers and their descendants, the company can access the Utah Tumor Registry. The registry has required that a record be kept of every cancer occurring in the state since 1973. Using these tools in combination has proved a powerful way of finding tumor genes.

The molecular diagnostic products marketed by Myriad Genetics are "designed to analyze genes and their mutations to assess an individual's risk for developing disease later in life or a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence, and measure a patient's exposure to drug therapy to ensure optimal dosing and reduced drug toxicity."18 Myriad's molecular diagnostic revenues in 2009 were $326.5 million, a 47% increase over the previous year. One reason for this profitability is that Myriad is currently the exclusive provider of tests for the BRCA1 and 2 genes, which are protected by patents. These patents, which are under legal challenge (Chapter 5, "Genes and cancer"), prevent gene-testing companies like 23andme or deCODE genetics from offering tests for these genes, although they do offer tests for other potential genetic risk factors for breast cancer. This is a potential source of confusion for the uninitiated because these companies assess some, but not all, of the potential breast cancer genetic risk. This is why it is of critical importance for people sending off a saliva or cheek swab sample to a gene-testing company to consult with professionals who can inform them as to exactly what the tests will and will not tell them.

One advantage the Mormon population lacks for gene hunters is that, unlike the Amish, it is not inbred.19 Although Brigham Young founded Salt Lake City in July 1847 with around 2,000 followers, colonization proceeded rapidly so that by 1890, when most immigration into Utah had ended, there was a total population of 205,889, of whom about 70% were Mormons. They included a great many Mormon converts who frequently came from Great Britain and Scandinavia.

Certain populations benefit the gene hunter by originating from small founding populations. Just by chance, this sometimes means that a deleterious gene may be amplified in the founding population as compared with the population from which it was derived. For example, Tay-Sachs is a common genetic disease among Ashkenazi Jews. Suppose you have a settlement containing 100 couples (excluding children for the purpose of the example) giving a population of 200. Suppose that 10 individuals are carriers of the gene. This yields a carrier frequency of 5%. If 10 couples from the original population decide to form a new settlement and, by chance, they include the 10 carriers, the frequency of carriers rises to 50%. This is the founder effect and accounts for the high frequency of some genetic diseases among certain populations (see Chapter 3, "Ethnicity and genetic disease").

When such a population can be identified and has remained relatively homogenous, it becomes an attractive target for a gene-hunting company. At the Genome 2001 Tri-conference held in San Francisco in March 2001, Phillipe Douville, Vice President and Chief Business Officer of Galileo Genomics Inc. of Montreal, remarked that the "main recognized founder populations in the world are those of Quebec, Finland, Sardinia, Iceland, Costa Rica, the northern Netherlands, Newfoundland, and several discrete ethnic groups including the Ashkenazi Jews."20

In fact, it was the population of Quebec that Galileo, now called Genizon BioSciences, planned to focus on. About 15,000 French settlers arrived in eastern Canada in the course of the seventeenth century.21 Around 2,600 of these hardy souls made their way to Quebec. This population has expanded 800 times over the ten generations since, with intermarriage within the group predominating. Thus, the Quebec founder population is relatively homogenous. Genizon BioSciences claims to have over 47,000 subjects in its biobank, 95% of whom have authorized the company to contact them again.22 Genizon has research teams investigating eight complex conditions, including Alzheimer's disease, obesity, and schizophrenia by means of genome wide association studies. The company hopes to identify specific patterns of genetic variation that correlate with these conditions and, ultimately, to tie each condition to specific genetic markers (see Chapters 3 and 4 for a fuller discussion).

Gene hunting can be an expensive and unprofitable business. It is usually supported for a while by grants, contracts, venture capital, and deep-pocketed drug companies, but, eventually, it must be profitable. The fate of IDgene Pharmaceuticals Ltd., a Jerusalem genomics start-up founded in 1999, shows what can happen when the path to profitability is not achieved soon enough.

The founder effect, coupled with homogeneity and inbreeding, means that the Ashkenazi Jews are favorable material for the discovery of new disease and susceptibility genes. Hence, IDgene Pharmaceuticals' goal was to search for disease genes among the Ashkenazim.23 Suitable patients with major chronic ailments that had four Ashkenazi grandparents were asked to donate a single blood sample for genetic testing. Written consent was required and the results were kept anonymous. Israeli Ashkenazi Jews suffering from asthma, type 2 diabetes, schizophrenia, Parkinson's disease, Alzheimer's disease, breast cancer, and colon cancer were studied. Using this method, the company's president, Dr. Ariel Darvasi, and colleagues reported strong genetic evidence supporting the hypothesis that a gene called COMT encoding an enzyme involved in the breakdown of certain neurotransmitters is involved in schizophrenia (see Chapter 6, "Genes and behavior").24 But, subsequently, IDgene failed to raise sufficient capital to continue in operation and closed down in 2004.25

  • + Share This
  • 🔖 Save To Your Account

InformIT Promotional Mailings & Special Offers

I would like to receive exclusive offers and hear about products from InformIT and its family of brands. I can unsubscribe at any time.


Pearson Education, Inc., 221 River Street, Hoboken, New Jersey 07030, (Pearson) presents this site to provide information about products and services that can be purchased through this site.

This privacy notice provides an overview of our commitment to privacy and describes how we collect, protect, use and share personal information collected through this site. Please note that other Pearson websites and online products and services have their own separate privacy policies.

Collection and Use of Information

To conduct business and deliver products and services, Pearson collects and uses personal information in several ways in connection with this site, including:

Questions and Inquiries

For inquiries and questions, we collect the inquiry or question, together with name, contact details (email address, phone number and mailing address) and any other additional information voluntarily submitted to us through a Contact Us form or an email. We use this information to address the inquiry and respond to the question.

Online Store

For orders and purchases placed through our online store on this site, we collect order details, name, institution name and address (if applicable), email address, phone number, shipping and billing addresses, credit/debit card information, shipping options and any instructions. We use this information to complete transactions, fulfill orders, communicate with individuals placing orders or visiting the online store, and for related purposes.


Pearson may offer opportunities to provide feedback or participate in surveys, including surveys evaluating Pearson products, services or sites. Participation is voluntary. Pearson collects information requested in the survey questions and uses the information to evaluate, support, maintain and improve products, services or sites, develop new products and services, conduct educational research and for other purposes specified in the survey.

Contests and Drawings

Occasionally, we may sponsor a contest or drawing. Participation is optional. Pearson collects name, contact information and other information specified on the entry form for the contest or drawing to conduct the contest or drawing. Pearson may collect additional personal information from the winners of a contest or drawing in order to award the prize and for tax reporting purposes, as required by law.


If you have elected to receive email newsletters or promotional mailings and special offers but want to unsubscribe, simply email information@informit.com.

Service Announcements

On rare occasions it is necessary to send out a strictly service related announcement. For instance, if our service is temporarily suspended for maintenance we might send users an email. Generally, users may not opt-out of these communications, though they can deactivate their account information. However, these communications are not promotional in nature.

Customer Service

We communicate with users on a regular basis to provide requested services and in regard to issues relating to their account we reply via email or phone in accordance with the users' wishes when a user submits their information through our Contact Us form.

Other Collection and Use of Information

Application and System Logs

Pearson automatically collects log data to help ensure the delivery, availability and security of this site. Log data may include technical information about how a user or visitor connected to this site, such as browser type, type of computer/device, operating system, internet service provider and IP address. We use this information for support purposes and to monitor the health of the site, identify problems, improve service, detect unauthorized access and fraudulent activity, prevent and respond to security incidents and appropriately scale computing resources.

Web Analytics

Pearson may use third party web trend analytical services, including Google Analytics, to collect visitor information, such as IP addresses, browser types, referring pages, pages visited and time spent on a particular site. While these analytical services collect and report information on an anonymous basis, they may use cookies to gather web trend information. The information gathered may enable Pearson (but not the third party web trend services) to link information with application and system log data. Pearson uses this information for system administration and to identify problems, improve service, detect unauthorized access and fraudulent activity, prevent and respond to security incidents, appropriately scale computing resources and otherwise support and deliver this site and its services.

Cookies and Related Technologies

This site uses cookies and similar technologies to personalize content, measure traffic patterns, control security, track use and access of information on this site, and provide interest-based messages and advertising. Users can manage and block the use of cookies through their browser. Disabling or blocking certain cookies may limit the functionality of this site.

Do Not Track

This site currently does not respond to Do Not Track signals.


Pearson uses appropriate physical, administrative and technical security measures to protect personal information from unauthorized access, use and disclosure.


This site is not directed to children under the age of 13.


Pearson may send or direct marketing communications to users, provided that

  • Pearson will not use personal information collected or processed as a K-12 school service provider for the purpose of directed or targeted advertising.
  • Such marketing is consistent with applicable law and Pearson's legal obligations.
  • Pearson will not knowingly direct or send marketing communications to an individual who has expressed a preference not to receive marketing.
  • Where required by applicable law, express or implied consent to marketing exists and has not been withdrawn.

Pearson may provide personal information to a third party service provider on a restricted basis to provide marketing solely on behalf of Pearson or an affiliate or customer for whom Pearson is a service provider. Marketing preferences may be changed at any time.

Correcting/Updating Personal Information

If a user's personally identifiable information changes (such as your postal address or email address), we provide a way to correct or update that user's personal data provided to us. This can be done on the Account page. If a user no longer desires our service and desires to delete his or her account, please contact us at customer-service@informit.com and we will process the deletion of a user's account.


Users can always make an informed choice as to whether they should proceed with certain services offered by InformIT. If you choose to remove yourself from our mailing list(s) simply visit the following page and uncheck any communication you no longer want to receive: www.informit.com/u.aspx.

Sale of Personal Information

Pearson does not rent or sell personal information in exchange for any payment of money.

While Pearson does not sell personal information, as defined in Nevada law, Nevada residents may email a request for no sale of their personal information to NevadaDesignatedRequest@pearson.com.

Supplemental Privacy Statement for California Residents

California residents should read our Supplemental privacy statement for California residents in conjunction with this Privacy Notice. The Supplemental privacy statement for California residents explains Pearson's commitment to comply with California law and applies to personal information of California residents collected in connection with this site and the Services.

Sharing and Disclosure

Pearson may disclose personal information, as follows:

  • As required by law.
  • With the consent of the individual (or their parent, if the individual is a minor)
  • In response to a subpoena, court order or legal process, to the extent permitted or required by law
  • To protect the security and safety of individuals, data, assets and systems, consistent with applicable law
  • In connection the sale, joint venture or other transfer of some or all of its company or assets, subject to the provisions of this Privacy Notice
  • To investigate or address actual or suspected fraud or other illegal activities
  • To exercise its legal rights, including enforcement of the Terms of Use for this site or another contract
  • To affiliated Pearson companies and other companies and organizations who perform work for Pearson and are obligated to protect the privacy of personal information consistent with this Privacy Notice
  • To a school, organization, company or government agency, where Pearson collects or processes the personal information in a school setting or on behalf of such organization, company or government agency.


This web site contains links to other sites. Please be aware that we are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of each and every web site that collects Personal Information. This privacy statement applies solely to information collected by this web site.

Requests and Contact

Please contact us about this Privacy Notice or if you have any requests or questions relating to the privacy of your personal information.

Changes to this Privacy Notice

We may revise this Privacy Notice through an updated posting. We will identify the effective date of the revision in the posting. Often, updates are made to provide greater clarity or to comply with changes in regulatory requirements. If the updates involve material changes to the collection, protection, use or disclosure of Personal Information, Pearson will provide notice of the change through a conspicuous notice on this site or other appropriate way. Continued use of the site after the effective date of a posted revision evidences acceptance. Please contact us if you have questions or concerns about the Privacy Notice or any objection to any revisions.

Last Update: November 17, 2020